TY - JOUR AU - Zhang, Tengyue AU - Pang, Chong AU - Li, Ningdong AU - Zhou, Elaine AU - Zhao, Kanxing PY - 2013 DA - 2013/01/02 TI - Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis JO - BMC Medicine SP - 1 VL - 11 IS - 1 AB - Mounting evidence has suggested that plasminogen activator inhibitor-1 (PAI-1) is a candidate for increased risk of diabetic retinopathy. Studies have reported that insertion/deletion polymorphism in the PAI-1 gene may influence the risk of this disease. To comprehensively address this issue, we performed a meta-analysis to evaluate the association of PAI-1 4G/5G polymorphism with diabetic retinopathy in type 2 diabetes. SN - 1741-7015 UR - https://doi.org/10.1186/1741-7015-11-1 DO - 10.1186/1741-7015-11-1 ID - Zhang2013 ER -